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Case history
In June 2009, a 29-year-old woman with a six-month 
history of human immunodeficiency virus (HIV) infection 
on highly active antiretroviral therapy (HAART) was referred 
to our endocrinology unit. She was on efavirenz 600 mg 
per os nocte and lamzid one tablet per os twice daily. Her 
presenting complaints were a one-month history of malaise 
and fatigue, dyspnoea with poor effort tolerance, recent 
weight gain and darkening of her skin.
Physical examination revealed a normotensive Cushingoid 
young woman with central obesity and moon facies. She 
had purple striae over her flanks and thighs. She had facial 
acne, bruising on her forearms and hyperpigmentation of 
her extensor surfaces on her upper and lower limbs. Thyroid 
examination was normal. A significant right inguinal lymph 
node was palpable, which was fixed and nontender. On 
rectal examination a worrying ulcer was noted on her anus.
Blood test results showed severe hypokalaemic metabolic 
alkalosis with serum potassium 2.3 mmol/l (normal 
3.3-5.3 mmol/l) and serum bicarbonate 39 mmol/l (normal 
18-29 mmol/l). C-reactive protein (CRP) was 4.1 mg/l, white 
blood cell count 4.4 x 109/l (neutrophils 80.8%) and absolute 
CD4 count 81 x 106/l. The patient had normochromic 
macrocytic anaemia and a mean cell volume (MCV) of 
110.3 fl (normal 79.1-98.9 fl) with normal serum folate and 
vitamin B12 levels. The macrocytosis was attributed to 
the antiretroviral therapy. Random serum cortisol was in 
excess of 2 069 nmol/l (normal values for adults 07h00-
09h00: 120-620 nmol/l; 15h00-17h00: 85-460 nmol/l) with 
adrenocorticotropic hormone (ACTH) significantly increased 
at 742.0 ng/l (normal < 46 ng/l). Thyroid function tests, 
serum aldosterone, alpha foetoprotein, luteinising hormone, 
follicle-stimulating hormone and oestradiol levels were all 
within normal limits. Early morning fasting plasma glucose 
levels were repeatedly > 7.0 mmol/l, and a new diagnosis of 
diabetes was made. Liver function tests, urea and creatinine 
were also within normal limits. The chest radiograph showed 
right midzone consolidation but without features suggestive 
of pulmonary tuberculosis. Initial sputa sent for tuberculosis 
microscopy (auramine stain) revealed no acid-fast bacilli.
A working diagnosis of ectopic ACTH syndrome (EAS) was 
suggested and a 24-hour urine collection for urine-free 
cortisol level was done. The 24-hour urinary cortisol value 
was 2 691 nmol/24 hours (normal 80-590 nmol/24 hours). 
Standard overnight low-dose (1 mg) and high-dose (8 mg) 
dexamethasone suppression tests were subsequently 
done. The former test had a result of cortisol level 
> 2 069 nmol/l, and the latter failed to suppress cortisol by 
68%, thus supporting the diagnosis of EAS. In the interim the 
patient received daily intravenous potassium replacement. 
Her liver function tests were normal, hence ketoconazole 
was used as an inhibitor for glucocorticoid biosynthesis. 
The dose of ketoconazole was gradually increased to a 
dosage of 400 mg per os twice daily. Despite this therapy 
cortisol levels remained in excess of 2 069 nmol/l.
On the ninth day of hospitalisation a computerised 
tomography (CT) scan of the chest and abdomen revealed 
a locally invasive rectal tumour with probable metastasis 
to the lung (Figure 1). The patient was then prepared 
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for sigmoidoscopy and tissue biopsy; however, during 
bowel preparation she bled significantly per rectum, and 
complained of excruciating pain, hence the procedure 
was abandoned. The colorectal unit was involved and on 
day 16 the patient was examined under anaesthesia and a 
diagnostic biopsy was taken. An obstructive rectal tumour 
was identified which necessitated the performance of a 
diverting loop colostomy. 
In addition, CT scans also confirmed the presence of 
symmetrically enlarged adrenal glands with no focal lesions. 
This was considered to be consistent with a diagnosis of 
adrenal hyperplasia secondary to chronic exposure to 
excess ACTH (Figure 2). Furthermore, chest CT revealed a 
lung lesion consistent with a neoplastic mass (Figure 3).
Cortisol levels persisted and she remained emotionally 
labile and hypokalaemic (despite aggressive replacement) 
and required relatively high doses of insulin to control her 
glucose levels. She used 20 IU of Actraphane® twice daily 
and on average required 24 IU of Actrapid® as top-up over 
24 hours as per sliding scale reading. 
Histopathological examination of the biopsy from the 
anus showed ulceration of the squamous epithelium, 
beneath which there was extensive infiltration of the 
perianal soft tissue by discohesive nests of small cells with 
hyperchromatic nuclei having finely stippled chromatin 
with a salt-and-pepper-like appearance (Figure 4). Small, 
eosinophilic nucleoli were present. The cells also had a 
moderate amount of pale staining cytoplasm, and while 
occasional nuclear moulding was evident, this was not a 
prominent feature. Occasional mitoses were identified 
together with focal necrosis.
Immunohistochemistry showed paranuclear, dot-like, 
positive staining for the pankeratins MNF 116 and 
AE1/3, together with positive cytoplasmic staining for 
synaptophysin, chromogranin A and ACTH in the malignant 
cells (Figure 5). Strong nuclear staining for thyroid 
transcription factor 1 (TTF-1) was also obtained, and the 
proliferative index was assessed to be 60-70% using the 
Ki-67 antibody. 
The overall appearance was interpreted to be compatible 
with that of a poorly differentiated neuroendocrine 
carcinoma. 
Intriguingly, closer examination of the granulation tissue 
associated with the area of ulceration also showed that 
many of the endothelial cells contained intranuclear and 
intracytoplasmic eosinophilic inclusions in keeping with 
coexistent cytomegalovirus infection, this being confirmed 
with positive staining on immunohistochemistry.
Despite aggressive supportive and specific therapy, the 
disease course was complicated by nosocomial sepsis and 
septic shock, as evidenced by a raised CRP value of 156 
mg/l, temperature spikes and hypotension. On day 24 a 
Figure 1: Computerised tomography image of an irregular bulky rectal 
mass measuring 12.1 × 5.3 cm. There is no plane of separation with 
the cervix and the distal third of the vagina. There is infiltration of 
pararectal fat. The bladder is spared.
Figure 2: Computerised tomography image of symmetrically enlarged 
adrenal glands with no focal lesions
Figure 3: Mediastinal window of the chest revealing an 
intraparenchymal lesion measuring 4.8 × 5.1 cm (red arrow)
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repeated sputal microscopy for tuberculosis was reported 
positive for acid-fast bacilli (more than 10/immersion field). 
Antituberculotic therapy was initiated. The patient eventually 
succumbed on day 28. Her family did not consent to a post 
mortem examination, hence it was not possible to confirm 
the nature of the pulmonary lesion histologically.
Discussion
EAS is a rare disease.1 Approximately 50% of cases are 
associated with intrathoracic tumours, usually small-cell 
neuroendocrine carcinomas.2 Other well-described tumours 
of ectopic ACTH production include thymic carcinoid (15%), 
islet cell tumours (10%), bronchial carcinoid (10%), other 
carcinoids (5%) and phaeochromocytomas (2%).2,3 
Diagnosing EAS is often difficult; none of the dynamic 
biochemical tests achieves 100% accuracy.2,4,5 The 
percentage of tumours not identified despite extensive 
evaluation is between 12% and 19%.2 Imaging is essential 
for determining the source of ACTH in ectopic ACTH 
production. CT of the chest, abdomen and pelvis with 
intravenous injection of contrast medium is the most 
sensitive imaging modality for the identification of the 
ectopic ACTH source.5 
Because of extremely high cortisol levels, patients may 
experience depression or personality changes, as in 
our case.3,5 Metabolic derangements tend to be more 
pronounced in EAS.2,3 Opportunistic infections caused by 
Pneumocystis jirovecii and mycoses are often the cause 
of death.3 Medical therapy is often the most practical 
strategy for managing hypercortisolism caused by EAS; 
unfortunately, many patients will eventually progress despite 
medical blockade.2,3,6,7
We are only aware of three other cases in the literature of a 
similar presentation of ectopic Cushing’s syndrome at this 
unusual site.7-9 
In our patient the histopathological features were interpreted 
to be compatible with a poorly differentiated neuroendocrine 
carcinoma (according to the World Health Organization 
2010 classification of neuroendocrine tumours) and the 
possibility of a metastatic origin was considered given 
the positive staining for TTF-1. Although nuclear TTF-1 is 
generally considered a specific marker for lung and thyroid 
neoplasm, it has been reported to be positive in other 
types of tumour, including colorectal carcinoma,10 and 
therefore close clinicopathological correlation is required for 
interpretation of positivity in cases such as the present one. 
While most anorectal cancers are squamous cell 
carcinomas, they may occasionally exhibit small-cell 
undifferentiated histological features, as in our patient.9 
These tumours are highly aggressive with distant metastasis 
common at presentation.9 Whenever a diagnosis of small-
cell neuroendocrine carcinoma is made, it is important to 
exclude metastasis secondary to carcinoid tumour and 
bronchogenic oat cell carcinoma, which may also resemble 
“small-cell” anaplastic tumours. Given the lack of histology 
from the lung lesion, the question of metastatic tumour or 
Figure 4: Histology of the anal biopsy reveals extensive infiltration 
by nests of discohesive small cells with moderate amounts of 
eosinophilic cytoplasm and small, inconspicuous nucleoli. The insets 
demonstrate positive immunohistochemical staining for ACTH in the 
cytoplasm (top) and strong intranuclear immunohistochemical staining 
for TTF-1(bottom).
Figure 5: Light microscopic images demonstrating positive 
neuroendocrine markers. Top: chromogranin A, bottom: 
synaptophysin.
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two unrelated (synchronous) tumours cannot be resolved. 
Nevertheless, the overall clinical features in this case would 
favour a primary neuroendocrine tumour of the anal canal 
which had spread to the lung. This is supported by the 
clinical presentation of anal canal obstruction with inguinal 
adenopathy, the latter consistent with local lymphatic 
spread. 
There is a marked increase in the incidence of both anal 
intraepithelial neoplasia (AIN) and invasive anal squamous 
cell carcinoma in individuals who are HIV infected. It is 
unclear whether HIV infection itself has a direct effect 
on the development of anal cancer or whether this is 
mediated through human papillomavirus (HPV) infection.11 
Patients with a longer duration of HIV infection have a 
substantially higher rate of anal cancer, but in contrast to 
other AIDS-associated cancers, the use of HAART has not 
led to a decline in the incidence of anal cancer.12 Without 
controlling for receptive anal intercourse and prior HPV 
infection, it is difficult to discern the true effect of HIV on 
the incidence of anal cancer. It is possible that HIV infection 
interacts with HPV to predispose to anal cancer.11,13 Chronic 
immunosuppression in HIV infection is also associated with 
a greater risk of progression from low-grade AIN to high-
grade AIN or invasive cancer.14 
Conclusion
This case clearly demonstrates all the challenges confronting 
the clinician when treating EAS; from investigating, 
diagnosing and treating the disease. A multidisciplinary 
management strategy involving endocrinologists, 
oncologists, surgeons, pathologists and psychologists 
needs to be employed when treating patients with this 
disease. Despite the aggressive treatment given (which the 
disease demands) often patients eventually succumb to 
opportunistic infections, as in our case. 
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